RecruitingNot Applicable

Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy

France250 participantsStarted 2022-10-26

Plain-language summary

The patient presents to the ophthalmological emergencies and / or to the internal medicine department. NOIA clinical discovery Patient referred in radiology for brain and visual MRI. The two sequences added by the research (8 minutes) will be added to that of the treatment.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient over 18 years old * Patient with suspected NOIA, evoked after clinical examination by a specialized ophthalmologist * For which a brain and visual MRI is planned * Express consent to participate in the study * Affiliate or beneficiary of a Social Security scheme Exclusion Criteria: * Contraindication to MRI (electrical device, metallic foreign body, claustrophobia) * Patient benefiting from a legal protection measure * Pregnant or breastfeeding woman

What they're measuring

Study the sensitivity of the High resolution Diffusion sequence in the detection of NOIA, evaluated by a DWI hypersignal and an ADC hyposignal of the optic nerve

Timeframe: basline

Trial details

NCT IDNCT04451265

SponsorFondation Ophtalmologique Adolphe de Rothschild

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2027-09

Contact for this trial

Amelie YAVCHITZ

0148036431 ayavchitz@for.paris

View on ClinicalTrials.gov More Neuro-Ophthalmology trials